Current through Reg. 49, No. 38; September 20, 2024
(a) Reporting entities described in §
97.132
of this title (relating to Who Shall Report Sexually Transmitted Diseases)
shall report all information required by the department for each person (which
includes an HIV-exposed infant) who has or is suspected of having an STD, as
well as for any specimen derived from a human body that yields microscopic,
cultural, serological or any other evidence of a suspected STD.
(b) The department has established the
reporting procedures required under Texas Health and Safety Code, §
81.044,
including the designation of specific forms and methods of reporting. The
required written reports, electronic reports, and telephone reports shall be
made in a complete, accurate and timely manner, all in accordance with §
97.134
of this title (relating to How to Report Sexually Transmitted
Diseases).
(c) All persons required
to report under §
97.132
of this title must report the following (each report must either use the
department's form specified in this subsection, or a substitute form which
captures all the data elements of the specified department form):
(1) All adult or adolescent (13 years of age
or older) HIV infections and AIDS (stage 3 of HIV infection) diagnoses for
individuals 13 years of age or older (see the most current version of the
department's Texas HIV/AIDS Adult/Adolescent case report form (available as
specified in §
97.134
of this title)).
(2) All pediatric
(less than 13 years of age) HIV infections and AIDS (stage 3 of HIV infection)
diagnoses (see the most current version of the department's Texas HIV/AIDS
pediatric case report form (available as specified in §
97.134
of this title)).
(3) All
HIV-positive pregnant women. (see the most current version of the department's
Texas HIV/AIDS Adult/Adolescent case report form (available as specified in
§
97.134
of this title)).
(4) All
HIV-exposed infants (see the most current version of the department's Texas
HIV/AIDS Pediatric case report form (available as specified in §
97.134
of this title)).
(5) All chancroid,
Chlamydia trachomatis, Neisseria gonorrhea, and syphilis infections (see the
most current version of the department's Confidential Report of Sexually
Transmitted Diseases form (STD-27) (available as specified in §
97.134
of this title)).
(6) All congenital
syphilis infections (see the most current version of the CDC's Congenital
Syphilis Case Investigation and Report form (available as specified in §
97.134
of this title)).
(7) All positive
or reactive results from point of care testing for STDs (see the most current
version of the department's Confidential Report of Sexually Transmitted
Diseases form (STD-27) (available as specified in §
97.134
of this title)).
(d)
Persons described in §
97.132(a)(2)
of this title must report the following regarding any specimen derived from a
human body that yields microscopic, cultural, serological or any other evidence
of a suspected STD (each report must either use the department's form specified
in this subsection, or a substitute form which captures all the data elements
of the specified department form):
(1) All
positive or reactive STD test results, including screening tests; all HIV viral
loads (detectable and non-detectable); and all CD4+T-lymphocyte cell counts and
percentages (see the most current version of the department's Notification of
Laboratory Test Findings Indicating Presence of Chlamydia trachomatis,
Gonorrhea, Syphilis, Chancroid, HIV Infections or CD4 Counts form (STD-28)
(available as specified in §
97.134
of this title)).
(2) HIV DNA or RNA
virologic tests on all infants suspected of HIV exposure from birth to three
years of age, regardless of the test findings (e.g., negative or positive) (see
the most current version of the department's STD-28 form (available as
specified in §
97.134
of this title)).
(3) All
supplemental tests for syphilis and HIV that result from an initial positive
screening test, regardless of result (e.g., reactive or non-reactive) (see the
most current version of the department's STD-28 form (available as specified in
§
97.134
of this title)).
(4) All HIV
nucleotide sequences that are resultant of genotypic testing, including HIV
drug resistance testing (see the most current version of the department's
STD-28 form (available as specified in §
97.134
of this title)).
